Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -97.98% lower on its value in year-to-date trading and has touched a low of $0.08 and a high of $7.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.09, the stock is -9.51% and -17.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.27 million and changing 0.22% at the moment leaves the stock -93.96% off its SMA200. CDT registered -92.63% loss for a year compared to 6-month loss of -96.93%. The firm has a 50-day simple moving average (SMA 50) of $0.11222 and a 200-day simple moving average (SMA200) of $1.536385.
The stock witnessed a -13.28% gain in the last 1 month and extending the period to 3 months gives it a -41.52%, and is -9.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.16% over the week and 14.15% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $9.47M and $0.00M in sales. Distance from 52-week low is 16.73% and -98.82% from its 52-week high.
.
Conduit Pharmaceuticals Inc (CDT) Top Institutional Holders
52.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 7.97% of the company’s shares. The shares outstanding are 73.83M, and float is at 54.16M with Short Float at 6.59%. Institutions hold 4.06% of the Float.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
